Literature DB >> 17486368

Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study.

Walter J Koskinen1, Kjell Brøndbo, Hanna Mellin Dahlstrand, Tapio Luostarinen, Timo Hakulinen, Ilmo Leivo, Anco Molijn, Wim G Quint, Tov Røysland, Eva Munck-Wikland, Antti A Mäkitie, Ilmari Pyykkö, Joakim Dillner, Antti Vaheri, Leena-Maija Aaltonen.   

Abstract

PURPOSE: Human papillomavirus (HPV) has been linked to oropharyngeal carcinomas, but its role in laryngeal squamous cell carcinoma (LSCC) is not clear. A prospective multicenter study based on known tumor-cell percentage of fresh frozen carcinoma biopsies was established to determine the HPV prevalence. Moreover risk factors such as smoking, alcohol abuse, chronic laryngitis and gastroesophageal reflux disease (GERD) were evaluated
METHODS: Fresh-frozen laryngeal cancer biopsies from 108 patients in Finland, Norway, and Sweden were investigated. Patients whose biopsy samples contained at least 20% tumor tissue (N = 69) entered the study. HPV DNA was determined with MY09/11 and GP5+/6+ nested PCR and SPF10 PCR hybridization assay. Patients were examined by an ENT specialist and an extensive questionnaire concerning risk factors was filled in.
RESULTS: Only three patients (4.4%) harbored HPV DNA in their carcinoma sample. Heavy alcohol drinking was associated with an increased risk of death, advanced-stage disease, and younger age at diagnosis. Chronic laryngitis, GERD, and orogenital sex contacts were rare. Poor oral hygiene was not associated with survival, although it correlated with heavy drinking.
CONCLUSION: In our series HPV was not important in LSCC. Heavy drinking led to major mortality in LSCC and promoted early carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486368     DOI: 10.1007/s00432-007-0219-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  34 in total

1.  Prognostic factors and survival of laryngeal cancer patients from Turin, Italy. A population-based study.

Authors:  P Boffetta; F Merletti; F Faggiano; G Migliaretti; G Ferro; R Zanetti; B Terracini
Journal:  Am J Epidemiol       Date:  1997-06-15       Impact factor: 4.897

2.  comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.

Authors:  Maaike A P C van Ham; Judith M J E Bakkers; Gonneke K Harbers; Wim G V Quint; Leon F A G Massuger; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 3.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

4.  Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy.

Authors:  S Franceschi; R Talamini; S Barra; A E Barón; E Negri; E Bidoli; D Serraino; C La Vecchia
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

5.  Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.

Authors:  Chris Perrons; Rosanne Jelley; Bernhard Kleter; Wim Quint; Nicola Brink
Journal:  J Clin Virol       Date:  2005-04       Impact factor: 3.168

6.  Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus.

Authors:  B Kleter; L J van Doorn; L Schrauwen; A Molijn; S Sastrowijoto; J ter Schegget; J Lindeman; B ter Harmsel; M Burger; W Quint
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

7.  Estimating dose-response relationship between ethanol and risk of cancer using regression spline models.

Authors:  Jerry Polesel; Luigino Dal Maso; Vincenzo Bagnardi; Antonella Zucchetto; Antonella Zambon; Fabio Levi; Carlo La Vecchia; Silvia Franceschi
Journal:  Int J Cancer       Date:  2005-05-01       Impact factor: 7.396

8.  Supraglottic and glottic carcinomas: epidemiologically distinct entities?

Authors:  Eduardo De Stefani; Paolo Boffetta; Hugo Deneo-Pellegrini; Paul Brennan; Pelayo Correa; Fernando Oreggia; Alvaro L Ronco; María Mendilaharsu
Journal:  Int J Cancer       Date:  2004-12-20       Impact factor: 7.396

9.  Diagnostic delays in laryngeal carcinoma: professional diagnostic delay is a strong independent predictor of survival.

Authors:  Heikki Teppo; Petri Koivunen; Kalevi Hyrynkangas; Olli-Pekka Alho
Journal:  Head Neck       Date:  2003-05       Impact factor: 3.147

10.  Tobacco and diet as determinants of survival in male laryngeal cancer patients.

Authors:  P Crosignani; A Russo; G Tagliabue; F Berrino
Journal:  Int J Cancer       Date:  1996-01-26       Impact factor: 7.396

View more
  18 in total

1.  Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma.

Authors:  Marcela K Hassumi-Fukasawa; Fabiana A Miranda-Camargo; Márcia C M Guimarães; Renata T Simões; Eduardo A Donadi; Christiane P Soares; Edson G Soares
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-05       Impact factor: 2.503

2.  Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a.

Authors:  Shaofeng Mou; Zhongxin Zhou; Yukai He; Fuxing Liu; Lili Gong
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

3.  Smoking affects quality of life in patients with oral squamous cell carcinomas.

Authors:  Gertrud Krüskemper; Jörg Handschel
Journal:  Clin Oral Investig       Date:  2011-10-20       Impact factor: 3.573

Review 4.  Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.

Authors:  Ana Gradíssimo; Robert D Burk
Journal:  Expert Rev Mol Diagn       Date:  2017-02-20       Impact factor: 5.225

5.  GSTM1 null polymorphisms is associated with laryngeal cancer risk: a meta-analysis.

Authors:  Yong Zhang; Wei Chen; Jun-feng Ji; Zhi-yi Wang; Ming-hai Wu; Kai Zhang; Qiu-ping Wang
Journal:  Tumour Biol       Date:  2014-03-19

6.  Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.

Authors:  Xin-Jiang Ying; Pin Dong; Bin Shen; Jie Wang; Sang Wang; Guo Wang
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-30       Impact factor: 4.553

Review 7.  Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review.

Authors:  Tatyana Isayeva; Yufeng Li; Daniel Maswahu; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2012-07-03

8.  Expression and significance of TWIST, a zinc finger transcription factor, in laryngeal carcinoma among Chinese population: a meta-analysis.

Authors:  Zhaolan Xiang; Qi Li; Aoshuang Chang; Xianlu Zhuo; Xueyuan Zhang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  The epidemiology of laryngeal cancer in a country on the esophageal cancer belt.

Authors:  Babak Saedi; Ebrahim Razmpa; Mohammad Sadeghi; Mohammad Mojtahed; Ali Mojtahed
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2009-09-27

10.  Galectin-3 overexpression in invasive laryngeal carcinoma, assessed by computer-assisted analysis.

Authors:  Fabiana Alves Miranda; Marcela K Hassumi; Marcia C M Guimarães; Renata T Simões; Tarsia G A Silva; Régia C P Lira; Ana M Rocha; Celso T Mendes; Eduardo A Donadi; Christiane P Soares; Edson G Soares
Journal:  J Histochem Cytochem       Date:  2009-03-30       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.